U.S. Senator Tammy Baldwin (D-WI), a member of the Senate Committee on Health, Education, Labor and Pensions, is leading a bipartisan group of her colleagues in calling for enforcement action to address practices of pharmaceutical companies that threaten to undermine the 340B Drug Pricing Program during the COVID-19 public health emergency. Drug manufacturers have recently announced new burdensome requirements for the 340B program. Baldwin and her colleagues have sent a letter to Health and Human Services Secretary Alex Azar, asking him to take immediate enforcement action against pharmaceutical manufacturers.
Rural Reporter